March 2020

Rinvoq From AbbVie, Inc

March 15, 2020

Pharmacy Times

The FDA has approved Rinvoq (upadacitinib) to treat moderate to severe rheumatoid arthritis (RA) in adults who have had an inadequate response or intolerance to methotrexate (MTX).

Study Finds Bidirectional Relationship Between Asthma and Migraines

March 09, 2020

Pharmacy Times

In the first report of its kind, a recent study compiled Korean Health Insurance Review and Assessment Service data from 2002 to 2013 to evaluate a bidirectional association between asthma and migraines in Korean adults.